Drug:
Reaction: VISUAL IMPAIRMENT
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26919408 |
US |
63 | 2 |
Visual impairment, Eye irritation, Drug effect less than expected, |
||||
POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL, ACOLTREMON, EZETIMIBE, |
||||
| 202 | 26919423 |
US |
84 | 2 |
Visual impairment, Eye pain, Eye irritation, |
||||
ACOLTREMON, POLYVINYL ALCOHOL, POVIDONE, |
||||
| 203 | 26919438 |
US |
68 | 2 |
Visual impairment, Dry eye, Eye irritation, |
||||
ACOLTREMON, ALBUTEROL SULFATE, ALBUTEROL, FUROSEMIDE, LOSARTAN, MELOXICAM, PANTOPRAZOLE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, BUPROPION HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 204 | 26919439 |
US |
2 | |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, AMLODIPINE, CALCIUM, INSULIN ASPART INJECTION, INSULIN ASPART, FUROSEMIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ORAL SEMAGLUTIDE, MESALAMINE, ROSUVASTATIN, SPIRONOLACTONE, INSULIN DEGLUDEC, RIVAROXABAN, |
||||
| 205 | 26919458 |
GB |
67 | 1 |
Visual impairment, |
||||
DOXAZOSIN, DOXAZOSIN MESYLATE, AMLODIPINE, LANSOPRAZOLE, RAMIPRIL, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
| 206 | 26919501 |
US |
83 | 2 |
Dry eye, Visual impairment, |
||||
ACOLTREMON, ACOLTREMON, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 207 | 26919503 |
US |
60 | 2 |
Drug ineffective, Headache, Visual impairment, Eye irritation, |
||||
ACOLTREMON, HYDROCHLOROTHIAZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 208 | 26919519 |
US |
86 | 2 |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, AZATHIOPRINE, GABAPENTIN, |
||||
| 209 | 26919545 |
US |
67 | 2 |
Visual impairment, Dry eye, Eye irritation, Eye pain, |
||||
ACOLTREMON, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LOSARTAN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, POLYETHYLENE GLYCOL 3350, |
||||
| 210 | 26919569 |
US |
79 | 1 |
Visual impairment, Vision blurred, Myopia, Dry eye, Eye pain, |
||||
ACOLTREMON, |
||||
| 211 | 26919593 |
US |
1 | |
Visual impairment, |
||||
DAPAGLIFLOZIN, |
||||
| 212 | 26919638 |
US |
82 | 2 |
Visual impairment, Drug ineffective, |
||||
ACOLTREMON, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, |
||||
| 213 | 26919797 |
US |
65 | 2 |
Abnormal sensation in eye, Dry eye, Visual impairment, Fatigue, Eye irritation, Eye pain, |
||||
ACOLTREMON, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DULOXETINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, GABAPENTIN, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 214 | 26919882 |
US |
76 | 2 |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 215 | 26919898 |
US |
79 | 2 |
Visual impairment, Dry eye, |
||||
ACOLTREMON, CALCIUM, SACUBITRIL AND VALSARTAN, ERGOCALCIFEROL, |
||||
| 216 | 26919928 |
US |
||
Injury associated with device, Visual impairment, Product storage issue, Multiple use of single-use product, |
||||
INSULIN DEGLUDEC, |
||||
| 217 | 26920067 |
US |
79 | 2 |
Visual impairment, Vision blurred, Eye irritation, Eye pain, |
||||
ACOLTREMON, HYDROCHLOROTHIAZIDE, |
||||
| 218 | 26920091 |
US |
72 | 2 |
Ocular discomfort, Lacrimation increased, Eye discharge, Visual impairment, Dry eye, Eye pain, |
||||
ACOLTREMON, ACYCLOVIR, ALBUTEROL SULFATE, ALBUTEROL, AZELASTINE, CYCLOSPORINE, FLUTICASONE PROPIONATE NASAL, SERTRALINE, |
||||
| 219 | 26920190 |
US |
72 | 2 |
Visual impairment, Vision blurred, Dry eye, Eye irritation, |
||||
ACOLTREMON, AMLODIPINE, HYDROCHLOROTHIAZIDE, LOSARTAN, MELOXICAM, SIMVASTATIN, |
||||
| 220 | 26920333 |
US |
88 | 2 |
Visual impairment, Dry eye, Eye irritation, |
||||
ACOLTREMON, ACOLTREMON, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LISINOPRIL, LORAZEPAM, PROPRANOLOL HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 221 | 26920425 |
US |
83 | 2 |
Visual impairment, Eye pain, Eye irritation, Feeling abnormal, |
||||
NETARSUDIL, ACOLTREMON, AMLODIPINE, BRIMONIDINE, BRIMONIDINE TARTRATE, CYCLOSPORINE, LATANOPROST, TIMOLOL, |
||||
| 222 | 26920518 |
US |
82 | 2 |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, |
||||
| 223 | 26920593 |
US |
88 | 2 |
Visual impairment, Dry eye, |
||||
ACOLTREMON, AMLODIPINE, DOXAZOSIN, DOXAZOSIN MESYLATE, EMPAGLIFLOZIN, MELOXICAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DULAGLUTIDE, |
||||
| 224 | 26920657 |
US |
88 | 2 |
Lacrimation increased, Ocular discomfort, Visual impairment, Dry eye, |
||||
ACOLTREMON, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IPRATROPIUM BROMIDE, LOSARTAN, MONTELUKAST, RALOXIFENE, CYCLOSPORINE, |
||||
| 225 | 26920708 |
US |
48 | 2 |
Rhinorrhoea, Visual impairment, Eye irritation, |
||||
ACOLTREMON, |
||||
| 226 | 26920788 |
US |
75 | 2 |
Visual impairment, Eye pain, |
||||
ACOLTREMON, |
||||
| 227 | 26921008 |
74 | 2 | |
Visual impairment, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 228 | 26921247 |
GB |
67 | 1 |
Visual impairment, |
||||
DOXAZOSIN, DOXAZOSIN MESYLATE, AMLODIPINE, RAMIPRIL, LANSOPRAZOLE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
| 229 | 26921266 |
|||
Visual impairment, |
||||
TIRZEPATIDE, |
||||
| 230 | 26923708 |
65 | 1 | |
Back pain, Arthralgia, Myalgia, Arthralgia, Arthralgia, Sensitive skin, Neuropathy peripheral, Visual impairment, Drug hypersensitivity, Blood glucose increased, |
||||
EVOLOCUMAB, FENOFIBRATE, GLIMEPIRIDE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EZETIMIBE, MELOXICAM, |
||||
| 231 | 26909625 |
US |
2 | |
Eye operation, Eye disorder, Visual impairment, Vitreous floaters, |
||||
RISANKIZUMAB-RZAA, |
||||
| 232 | 26909814 |
EU |
19 | 1 |
Papilloedema, Uveitis, Visual impairment, |
||||
METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 233 | 26909838 |
CL |
51 | 2 |
Osteonecrosis, Metastasis, Neutrophil count decreased, Breast cancer, Malignant neoplasm progression, Rectal cancer, Second primary malignancy, Metastases to bone, Bone pain, Pain, Back pain, Illness, Sinus bradycardia, Full blood count abnormal, Mean cell volume increased, Mean cell haemoglobin increased, Red cell distribution width increased, Anisocytosis, Macrocytosis, Elliptocytosis, Confusional state, Pain in extremity, Movement disorder, Polychromic red blood cells present, Neutrophil toxic granulation present, Red blood cell poikilocytes present, Lymphocyte percentage abnormal, Red blood cell count increased, Blood alkaline phosphatase decreased, Vision blurred, Red blood cell count decreased, White blood cell count decreased, Blood creatinine abnormal, Blood urea abnormal, Aspartate aminotransferase increased, Platelet count decreased, Platelet count decreased, Gait disturbance, Visual impairment, Eating disorder, Overweight, Insomnia, Anxiety, Depressed mood, Cytogenetic analysis abnormal, Platelet count increased, Inappropriate schedule of product administration, |
||||
FULVESTRANT, LETROZOLE, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, VISCUM ALBUM FRUITING TOP, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 234 | 26910237 |
BR |
2 | |
Suicide attempt, Suicidal ideation, Asthenia, Pain, Feeling abnormal, Headache, Wound, Pruritus, Asphyxia, Neoplasm, Tumour pain, Apathy, Syncope, Swelling, Renal impairment, Cardiac arrest, Eye disorder, Cardiac arrest, Coronavirus infection, Pneumonia, Neoplasm malignant, Cardiomegaly, Neoplasm malignant, Pancreatic enlargement, Abnormal organ growth, Metastatic carcinoid tumour, Throat cancer, Metastasis, Metastasis, Disease recurrence, Metastases to bone, Diabetes mellitus, Arrhythmia, Acromegaly, Bone pain, Visual impairment, Bone marrow infiltration, Nervousness, Malaise, Cataract, Mass, Lung disorder, Bone disorder, Back pain, Agitation, Insomnia, Panic reaction, Feeding disorder, Fear, Fatigue, Stress, Skin hypertrophy, Skin discolouration, Balance disorder, General physical condition abnormal, Hepatomegaly, Crying, Mood altered, Endocrine disorder, Deformity, Dyskinesia, Fall, Foot deformity, Dysphonia, Needle issue, Productive cough, Dyspnoea, Influenza like illness, Headache, Oropharyngeal pain, Incorrect dose administered, Product quality issue, Product storage error, Product physical issue, Inappropriate schedule of product administration, Muscular weakness, Myalgia, Coating in mouth, Hormone level abnormal, Therapeutic product effect delayed, Dyspnoea, Cardiac disorder, Tongue disorder, Liver disorder, Pancreatic disorder, Gallbladder disorder, Headache, Vomiting, Injection site pain, Decreased appetite, Bacteroides test positive, Head injury, Malaise, Retching, Cyanosis, Cardiac valve disease, Asthenia, Sluggishness, Platelet count decreased, Decreased immune responsiveness, Haemangioma of bone, Neuralgia, Anxiety, Gait disturbance, Malaise, Pyrexia, Yellow skin, Skin discolouration, Gait disturbance, Laziness, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, SERTRALINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 235 | 26910302 |
CA |
43 | 2 |
Fibromyalgia, Folliculitis, Gait disturbance, Incorrect route of product administration, Product use issue, Fatigue, Arthropathy, Autoimmune disorder, Breast cancer stage II, Abdominal discomfort, Hypocholesterolaemia, Retinitis, Visual impairment, Medication error, Off label use, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, OXYCODONE, OXYCODONE, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 236 | 26910791 |
GB |
88 | 2 |
Visual impairment, Asthenia, Dizziness, Hypersensitivity, |
||||
FLUCONAZOLE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FLURANDRENOLIDE, BISOPROLOL FUMARATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 237 | 26910943 |
US |
26 | 1 |
Blindness, Hyperhidrosis, Haematochezia, Pallor, Nausea, Visual impairment, Oropharyngeal pain, Malaise, Nocturia, Dizziness, Feeling abnormal, Hyperhidrosis, Suture insertion, Dizziness, Deafness, Dizziness, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 238 | 26911424 |
US |
72 | 1 |
Hip arthroplasty, Visual impairment, Polyarthritis, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 239 | 26911620 |
US |
39 | 2 |
End stage renal disease, Inability to afford medication, Insurance issue, Visual impairment, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 240 | 26911841 |
US |
15 | |
Vomiting, Headache, Visual impairment, |
||||
ISOTRETINOIN, |
||||
| 241 | 26912016 |
76 | 1 | |
Cataract, Visual impairment, Suspected off label use, |
||||
FINERENONE, |
||||
| 242 | 26912079 |
US |
79 | 2 |
Visual impairment, |
||||
DULAGLUTIDE, |
||||
| 243 | 26912091 |
ZA |
81 | 2 |
Retinal thickening, Visual impairment, Optical coherence tomography abnormal, Off label use, |
||||
FARICIMAB, FARICIMAB, |
||||
| 244 | 26912103 |
US |
2 | |
Wheelchair user, Visual impairment, |
||||
INSULIN ASPART, |
||||
| 245 | 26912140 |
US |
79 | 1 |
Drug ineffective, Lacrimation increased, Visual impairment, |
||||
SULFASALAZINE, ACOLTREMON, ATORVASTATIN CALCIUM, MEPOLIZUMAB, VALSARTAN, VALSARTAN ORAL, |
||||
| 246 | 26912211 |
EU |
1 | |
Eye infarction, Visual impairment, Optic nerve injury, Visual impairment, Eye pain, |
||||
TADALAFIL, |
||||
| 247 | 26912560 |
CA |
43 | 2 |
Abdominal discomfort, Weight increased, Rash, Wound, Abdominal pain upper, Irritable bowel syndrome, Retinitis, Vomiting, Memory impairment, Visual impairment, Musculoskeletal pain, Maternal exposure during pregnancy, Paraesthesia, Hepatic enzyme increased, General physical health deterioration, Impaired healing, C-reactive protein increased, Lung disorder, Psoriatic arthropathy, Joint range of motion decreased, Glossodynia, Red blood cell sedimentation rate increased, Anti-cyclic citrullinated peptide antibody positive, Dislocation of vertebra, Folliculitis, Taste disorder, Pain, Bursitis, Migraine, Asthenia, Peripheral swelling, Hypocholesterolaemia, Joint swelling, Dry mouth, Exostosis, Diarrhoea, Headache, Decreased appetite, Depression, Night sweats, Blister, Lupus vulgaris, Gastrooesophageal reflux disease, Peripheral venous disease, Blepharospasm, Breast cancer stage III, Dizziness, Arthralgia, Infusion related reaction, Pericarditis, Frequent bowel movements, Feeling hot, Osteoporosis, Synovitis, Exposure during pregnancy, Contraindicated product administered, Pyrexia, Back injury, Product quality issue, Blood cholesterol increased, Muscle spasms, |
||||
SECUKINUMAB, SECUKINUMAB, TOFACITINIB, TOFACITINIB CITRATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, MEPOLIZUMAB, OXYCODONE, OXYCODONE, TOFACITINIB, TOFACITINIB, METHYLPREDNISOLONE, METHYLPREDNISOLONE, PHENYLEPHRINE HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, PYRIDOXINE HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MINOCYCLINE HYDROCHLORIDE, APREMILAST, APREMILAST, BUPRENORPHINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CYCLOBENZAPRINE, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, MIRABEGRON, MIRABEGRON, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, GOLIMUMAB, GOLIMUMAB, ERENUMAB-AOOE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, TRAMADOL HYDROCHLORIDE, RAMIPRIL, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ABATACEPT, ABATACEPT, CELECOXIB, CELECOXIB, NAPROXEN, NAPROXEN SODIUM, RANITIDINE HYDROCHLORIDE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, VITAMIN C, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FISH OIL, QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RISEDRONATE SODIUM, ALBUTEROL SULFATE, LISINOPRIL, |
||||
| 248 | 26913222 |
US |
2 | |
Deafness, Blindness, Visual impairment, |
||||
RAVULIZUMAB, |
||||
| 249 | 26913323 |
US |
65 | 1 |
Rash macular, Eye pain, Visual impairment, Migraine, Arthralgia, Myalgia, Blood cholesterol increased, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 250 | 26913495 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Anxiety, Epilepsy, Ankle fracture, Migraine, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Vomiting, Nausea, Hypertension, Diarrhoea, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Foot fracture, Blood alkaline phosphatase increased, Dizziness, Haematocrit decreased, Haemoglobin decreased, White blood cell count decreased, Malaise, Headache, Abnormal behaviour, Emotional distress, Skin discolouration, Depression, Ligament sprain, Myopia, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Asphyxia, Choking, Petit mal epilepsy, Metastases to lung, Neoplasm malignant, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Depressed mood, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Electric shock sensation, Full blood count decreased, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Pain, Fluid retention, Fat tissue increased, Dry eye, Back pain, Abdominal discomfort, Diarrhoea, Fatigue, Headache, Dysgeusia, Memory impairment, Aversion, Blood sodium increased, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Elliptocytosis, Discomfort, Atrioventricular block first degree, Red cell distribution width increased, Red blood cell sedimentation rate increased, Blood glucose increased, Gastrointestinal disorder, Mean cell volume increased, Rouleaux formation, Limb deformity, Oral herpes, Ill-defined disorder, Thyroid mass, Visual impairment, Decreased immune responsiveness, Neoplasm, Arthritis, Gingival disorder, Pruritus, Hypersensitivity, Pyrexia, Red blood cell count decreased, Lymphocyte count decreased, Dry skin, Pain in extremity, Vision blurred, Herpes virus infection, Viral diarrhoea, Colitis, Chills, Agitation, Confusional state, Oesophagitis, Gastrooesophageal reflux disease, Stress, Catheter site pain, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Weight decreased, Nasopharyngitis, Alopecia, Tension headache, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, ERGOCALCIFEROL, CALCIUM, |
||||
| 251 | 26913694 |
US |
65 | |
Pericardial effusion, Visual impairment, Nystagmus, Eye swelling, Vision blurred, Adverse event, Epistaxis, Dizziness, Headache, Diarrhoea, |
||||
TREPROSTINIL, TREPROSTINIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, NINTEDANIB, ALLOPURINOL, FINASTERIDE, CYCLOSPORINE, ALBUTEROL SULFATE, AMLODIPINE AND ATORVASTATIN, OXYGEN, 0XYGEN, MONTELUKAST SODIUM, MONTELUKAST, IPRATROPIUM BROMIDE, |
||||
| 252 | 26914038 |
US |
1 | |
Visual impairment, |
||||
INSULIN ASPART, |
||||
| 253 | 26914168 |
US |
68 | 1 |
Visual impairment, |
||||
SIBEPRENLIMAB, FUROSEMIDE, INSULIN GLARGINE, MYCOPHENOLIC ACID, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, SODIUM ZIRCONIUM CYCLOSILICATE, TACROLIMUS, TACROLIMUS, |
||||
| 254 | 26914267 |
US |
80 | 2 |
Extra dose administered, Visual impairment, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 255 | 26914495 |
43 | 2 | |
Abdominal discomfort, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein increased, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Dislocation of vertebra, Dizziness, Dry mouth, Exostosis, Feeling hot, Folliculitis, Frequent bowel movements, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Headache, Hepatic enzyme increased, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lung disorder, Lupus vulgaris, Memory impairment, Migraine, Muscle spasms, Musculoskeletal pain, Night sweats, Osteoporosis, Pain, Paraesthesia, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Red blood cell sedimentation rate increased, Retinitis, Synovitis, Taste disorder, Visual impairment, Vomiting, Weight increased, Wound, Live birth, Exposure during pregnancy, Maternal exposure during pregnancy, Product quality issue, Product use in unapproved indication, |
||||
BETAMETHASONE DIPROPIONATE, |
||||
| 256 | 26914557 |
US |
75 | 1 |
Angle closure glaucoma, Cataract, Visual impairment, Incorrect dose administered, Injection site pain, Wrong technique in product usage process, |
||||
TERIPARATIDE, TERIPARATIDE, |
||||
| 257 | 26904645 |
US |
69 | 2 |
Visual impairment, |
||||
GALCANEZUMAB-GNLM, |
||||
| 258 | 26904668 |
US |
2 | |
Injury associated with device, Visual impairment, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 259 | 26904933 |
US |
2 | |
Intervertebral disc disorder, Feeling abnormal, Streptococcal infection, Granuloma, Limb discomfort, Pain in extremity, Mobility decreased, Secretion discharge, Soft tissue injury, Visual impairment, Swelling face, Face oedema, Eye swelling, Panic attack, Candida infection, Vision blurred, Monoclonal immunoglobulin increased, Vomiting, Defaecation disorder, Gastrooesophageal reflux disease, Nausea, Diarrhoea, Abdominal distension, Fatigue, Tooth disorder, Tooth abscess, Tooth fracture, Blood pressure increased, Blood cholesterol abnormal, Attention deficit hyperactivity disorder, Iron deficiency, Metabolic disorder, Vitamin B12 abnormal, Product dose omission issue, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, DOLUTEGRAVIR SODIUM AND LAMIVUDINE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, ATAZANAVIR, MAGNESIUM, |
||||
| 260 | 26905225 |
GB |
||
Atypical migraine, Pain, Balance disorder, Visual impairment, Hypoaesthesia, Chills, Tinnitus, |
||||
FAMOTIDINE, FAMOTIDINE, BECLOMETHASONE DIPROPIONATE, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, ALBUTEROL, ZOLMITRIPTAN, |
||||
| 261 | 26905251 |
US |
60 | 2 |
Visual impairment, Dizziness, Malaise, Extra dose administered, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 262 | 26905379 |
US |
71 | 1 |
Visual impairment, Ocular discomfort, |
||||
DUPILUMAB, |
||||
| 263 | 26905411 |
US |
2 | |
Visual impairment, Eye pain, Ocular discomfort, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 264 | 26905483 |
US |
84 | 2 |
Fall, Loss of consciousness, Blindness unilateral, Visual impairment, Cardiac murmur, Hypertension, |
||||
ACALABRUTINIB, CALCIUM, FLUVASTATIN SODIUM, |
||||
| 265 | 26905742 |
US |
73 | 1 |
Visual impairment, Gastrooesophageal reflux disease, Eructation, Abdominal discomfort, Diarrhoea, Constipation, |
||||
TIRZEPATIDE, |
||||
| 266 | 26906056 |
CA |
2 | |
Bronchitis, C-reactive protein, Colitis ulcerative, Drug-induced liver injury, Dyspepsia, Ear infection, Facet joint syndrome, Foot deformity, Frequent bowel movements, Hypersensitivity, Hypoaesthesia, Infection, Injury, Joint dislocation, Loss of personal independence in daily activities, Lower limb fracture, Malaise, Maternal exposure during pregnancy, Migraine, Mobility decreased, Nasopharyngitis, Osteoporosis, Pancreatitis, Porphyria acute, Pruritus, Retinitis, Rheumatic fever, Road traffic accident, Sciatica, Seronegative arthritis, Spondylitis, Swollen joint count increased, Visual impairment, |
||||
MEPOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, APREMILAST, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, BETAMETHASONE DIPROPIONATE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CANDESARTAN, CANDESARTAN, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUTICASONE PROPIONATE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, SARILUMAB, DICLOFENAC SODIUM, LANSOPRAZOLE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MESALAMINE, MINOCYCLINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ERGOCALCIFEROL, LEFLUNOMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, |
||||
| 267 | 26906216 |
GB |
68 | 2 |
Neuropathy peripheral, Visual impairment, Arthralgia, Myalgia, Headache, Rash, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 268 | 26906781 |
US |
92 | |
Keratic precipitates, Anterior chamber cell, Trabecular meshwork pigmentation, Visual impairment, Ear pain, Intraocular pressure increased, |
||||
AFLIBERCEPT, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CEPHALEXIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, FISH OIL, LISINOPRIL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, ERGOCALCIFEROL, VITAMIN E, |
||||
| 269 | 26906894 |
EU |
74 | |
Retinal injury, Visual impairment, |
||||
AFLIBERCEPT, |
||||
| 270 | 26906961 |
CH |
65 | |
Blindness, Macular ischaemia, Retinal vein occlusion, Visual impairment, Retinal occlusive vasculitis, Retinal haemorrhage, |
||||
AFLIBERCEPT, AFLIBERCEPT, AFLIBERCEPT, |
||||
| 271 | 26907065 |
US |
65 | 2 |
Visual impairment, Conjunctivitis, Eye discharge, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LEBRIKIZUMAB-LBKZ, EZETIMIBE, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ORAL SEMAGLUTIDE, ERGOCALCIFEROL, |
||||
| 272 | 26907136 |
KR |
67 | 1 |
Visual impairment, |
||||
FARICIMAB, FARICIMAB, |
||||
| 273 | 26907153 |
US |
45 | 1 |
Visual impairment, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 274 | 26907154 |
US |
49 | 2 |
Hypoacusis, Visual impairment, Inappropriate schedule of product administration, |
||||
TADALAFIL, |
||||
| 275 | 26907194 |
ZA |
1 | |
Optical coherence tomography abnormal, Visual impairment, Retinal thickening, |
||||
FARICIMAB, |
||||
| 276 | 26907201 |
EU |
44 | 2 |
Malaise, Asthenia, Dizziness, Visual impairment, Heavy menstrual bleeding, Poor venous access, |
||||
| 277 | 26907323 |
US |
72 | 2 |
Retinal occlusive vasculitis, Visual impairment, Hypersensitivity, |
||||
FARICIMAB, FARICIMAB, FARICIMAB, FARICIMAB, |
||||
| 278 | 26907366 |
US |
2 | |
Visual impairment, |
||||
EVOLOCUMAB, |
||||
| 279 | 26907518 |
CA |
43 | 2 |
Breast cancer stage II, Retinitis, Incorrect route of product administration, Off label use, Medication error, Fibromyalgia, Arthropathy, Folliculitis, Gait disturbance, Abdominal discomfort, Autoimmune disorder, Fatigue, Visual impairment, Hypocholesterolaemia, Product use issue, |
||||
DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, PREGABALIN, CELECOXIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, OXYCODONE, OXYCODONE, OXYCODONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, |
||||
| 280 | 26907532 |
GB |
2 | |
Cerebrovascular accident, Dizziness, Gait disturbance, Visual impairment, Eye movement disorder, Vision blurred, Cerebral disorder, Speech disorder, Chest pain, |
||||
SIPONIMOD, SIPONIMOD, |
||||
| 281 | 26907642 |
US |
72 | 1 |
Visual impairment, |
||||
DULAGLUTIDE, |
||||
| 282 | 26907878 |
EU |
56 | 2 |
Cardiac failure, Fatigue, Visual impairment, Constipation, Dry skin, Muscle twitching, Dysuria, Peripheral swelling, Pain, Arthralgia, Headache, Fine motor skill dysfunction, Weight increased, Asthenia, Myalgia, Balance disorder, Restlessness, Pain in extremity, Tremor, Urinary incontinence, Bundle branch block left, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, |
||||
| 283 | 26908055 |
US |
52 | 2 |
Visual impairment, Extra dose administered, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 284 | 26908069 |
1 | ||
Visual impairment, Blood pressure increased, Palpitations, |
||||
| 285 | 26908345 |
BR |
49 | 2 |
Coma, Cerebrovascular accident, Respiratory arrest, Extrasystoles, Movement disorder, Dysentery, Headache, Neoplasm malignant, Cerebrovascular accident, Syncope, Lipoma, Concomitant disease aggravated, Cerebral artery stenosis, Dysarthria, Diarrhoea, Diarrhoea, Limb deformity, Foot deformity, Epistaxis, Nasal oedema, Pain, Crying, Body height abnormal, Insomnia, Tooth malformation, Tooth disorder, Dental caries, Root canal infection, Teeth brittle, Tooth loss, Menopausal disorder, Discomfort, Speech disorder, Anger, Stress, Irritability, Malaise, Foot deformity, Deformity, Head discomfort, Paraesthesia, Limb discomfort, Blood pressure fluctuation, Hypertension, Neck pain, Hypotension, Nervousness, Hand deformity, Memory impairment, Visual impairment, Fatigue, Metabolic disorder, Ear discomfort, Condition aggravated, Hypoacusis, Product dose omission issue, |
||||
FLUOXETINE HYDROCHLORIDE, LOSARTAN, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, PREDNISONE, CAPTOPRIL, CABERGOLINE, |
||||
| 286 | 26908473 |
PA |
58 | 1 |
Rheumatoid factor, Prostatic specific antigen increased, Diverticulitis, Bradycardia, Urological examination abnormal, Weight decreased, Heat stroke, Choking, Anaphylactic reaction, Ill-defined disorder, Back pain, Memory impairment, Bladder discomfort, Dysuria, Hypoacusis, Conjunctivitis, Malaise, Sleep disorder, Muscle disorder, Fear, Visual impairment, Feeling abnormal, Somnolence, Pain, Lethargy, Fatigue, Blood urine present, Bacterial test positive, Urine abnormality, Asthenia, Tonsillitis, Infection, Anxiety, |
||||
CARBAMAZEPINE, AMLODIPINE, AMLODIPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, OXYCODONE, SIMVASTATIN, FENOFIBRATE, |
||||
| 287 | 26908891 |
US |
37 | 1 |
Visual impairment, Device issue, Device breakage, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 288 | 26908986 |
US |
51 | 1 |
Visual impairment, |
||||
INSULIN GLARGINE, |
||||
| 289 | 26909031 |
US |
59 | 2 |
Eructation, Diarrhoea, Visual impairment, Off label use, Off label use, |
||||
| 290 | 26909171 |
US |
1 | |
Visual impairment, |
||||
DIROXIMEL FUMARATE, |
||||
| 291 | 26909316 |
US |
51 | 2 |
Visual impairment, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 292 | 26903790 |
US |
2 | |
Pruritus, Burning sensation, Visual impairment, Vision blurred, |
||||
DUPILUMAB, |
||||
| 293 | 26903830 |
US |
43 | 2 |
Visual impairment, Eczema, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 294 | 26904312 |
US |
2 | |
Eye infection fungal, Dry eye, Visual impairment, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 295 | 26918180 |
61 | ||
Hypersensitivity, Febrile neutropenia, Vasculitis, Vascular stenosis, Hypertransaminasaemia, Gait disturbance, Loss of consciousness, Hepatic enzyme increased, Insomnia, Mood swings, Feeling abnormal, Hypothyroidism, Vitreous floaters, Visual impairment, Circulatory collapse, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PREDNISONE, |
||||
| 296 | 26902657 |
CA |
66 | 1 |
Visual impairment, Eye infection viral, Visual impairment, Thrombosis, Eye irritation, Erythema, |
||||
RISANKIZUMAB-RZAA, |
||||
| 297 | 26902689 |
US |
78 | 2 |
Nephrolithiasis, Vomiting, Choking, Ventricular dysfunction, Visual impairment, Hordeolum, Loss of consciousness, Alopecia, Cardiac flutter, Feeling hot, |
||||
THYROID, PORCINE, LEVOTHYROXINE SODIUM, |
||||
| 298 | 26902886 |
GB |
58 | 2 |
Visual impairment, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 299 | 26902946 |
US |
41 | 1 |
Visual impairment, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 300 | 26903580 |
US |
55 | 2 |
Surgery, Pancreatitis, Suspected COVID-19, Product storage issue, Incorrect dose administered, Stress, Visual impairment, Malaise, Influenza, Breast cancer, Pancreatic disorder, Radiotherapy, |
||||
PANCRELIPASE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30